Haw Par Corporation Limited H4V.F

Healthcare · Drug Manufacturers - General · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$4.07B
Market Cap
$1.98B
Margin of Safety
51.4%
Intrinsic / Market Ratio
2.06

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

4.34B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

3.82B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

4.04B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

4.07B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

4.07B USD

from the sum above

Market Cap

1.98B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

2.06×

the ratio the screener ranks by; Margin of Safety +51.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 4.34B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)830.35M USD
+②Net Cash Today3.42B USD
+③Growth Value90.88M USD
=Value4.34B USD

EPV of the Operations (NOPAT over WACC)

830.35M USD

Net cash today

+3.42B USD

Growth Value

+90.88M USD

Value

4.34B USD

①EPV (earnings power value)

830.35M USD

②Net Cash Today

3.42B USD

③Growth Value

90.88M USD

Market value

Market Cap1.98B USD

Today's price times the shares.

Value vs market

Margin of Safety+54.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 3.82B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.58B USD
+②Equity at Year 15, Today2.24B USD
=Value3.82B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.58B USD

②Equity at Year 15, Today

2.24B USD

Market value

Market Cap1.98B USD

Today's price times the shares.

Value vs market

Margin of Safety+48.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 4.04B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF431.17M USD
+②Invested Capital at Year 15, Today192.37M USD
+③Net Cash Today3.42B USD
=Value4.04B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

431.17M USD

②Invested Capital at Year 15, Today

192.37M USD

③Net Cash Today

3.42B USD

Market value

Market Cap1.98B USD

Today's price times the shares.

Value vs market

Margin of Safety+51.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.39%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.16×Market Risk Premium 6.00%= 5.45%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 12.62M USDPretax Income 219.59M USD= 5.75%

The tax the interest saves.

Interest Expense =EBIT 220.78M USD−Pretax Income 219.59M USD= 1.19M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 1.19M USDTotal Debt 40.75M USD×(1 − Tax Rate for WACC 5.75%)= 2.75%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 40.75M USDMarket Cap + Total Debt 1.98B USD + 40.75M USD= 2.02%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 97.98%×Cost of Equity 5.45%+Debt Weight 2.02%×Cost of Debt 2.75%= 5.39%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 3.78B USD − Total Liabilities 103.72M USD = Book Value Today 3.67B USD

Total Debt 40.75M USD − Cash and Short-Term Investments 3.46B USD = Net Debt Today -3.42B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes221,368,173 / 221,368,173
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-4.3%at least -10.0%passes(44.54M USD − 206.97M USD) ÷ 3.78B USD
Price to bookMarket Cap ÷ Book Value Today0.54×at most 3×passes1.98B USD ÷ 3.67B USD
Operating marginOperating Income ÷ Revenue29.2%above 10.0%passes52.31M USD ÷ 179.30M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-0.6%above 10.0%does not pass179.30M USD / 180.29M USD
Net cash(Cash − Total Debt) ÷ Market Cap24.1%above -30%passes(518.33M USD − 40.75M USD) ÷ 1.98B USD
Operating efficiencyOperating Income ÷ Gross Profit—above 25.0%not measured52.31M USD ÷ 0 USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

8 USD

Enterprise value

1.14B USD

market cap plus net debt

EV / EBITDA

15.74×

Price / book

0.53×

the provider's book

Price / earnings

11.54×

Return on equity

5.2%

the provider's, not the engine's

Profit margin

104.4%

Revenue growth

-8.2%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

135.67M176.01M180.29M179.30M

Gross profit

————

Operating income

32.32M48.55M47.01M52.31M

EBITDA

operating income before depreciation and amortisation

123.07M179.75M187.28M225.74M

Pretax income

118.44M173.98M181.25M219.59M

Net income

110.50M164.26M168.11M206.97M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

110.50M164.26M168.11M206.97M

R&D

————
Balance sheet, year end

Total assets

2.72B2.73B3.15B3.44B

Total liabilities

75.56M88.87M94.61M98.88M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

2.64B2.64B3.06B3.35B

Total debt

21.76M21.60M27.08M34.85M

Cash and equivalents

249.05M435.36M549.21M617.05M

Net PP&E

fixed assets after depreciation

37.55M37.61M36.87M38.96M

Working capital

current assets less current liabilities

2.35B2.42B2.88B3.25B
Cash flow

Operating cash flow

30.50M47.54M39.61M44.54M

Capital expenditure

paid out, so below zero

-14.70M-5.89M-2.55M-1.65M

Depreciation and amortisation

4.23M4.59M4.50M4.96M

Free cash flow

operating cash flow plus capital expenditure

15.80M41.65M37.06M42.89M